As depicted in Figure 6(a) and Supplemental Figure S6(a), both the expected amyloid-β 42/40 ratio and the expected amyloid-β 42/total tau ratio decrease with increasing age, implying a higher risk of progression to AD in older patients. Here, MAPT is linked to Alzheimer disease.